DiscoverThe IntelligenceShot chasers: big pharma’s covid-19 boost
Shot chasers: big pharma’s covid-19 boost

Shot chasers: big pharma’s covid-19 boost

Update: 2020-05-262
Share

Description

The pandemic has caused a shift in how drug firms are viewed: their capacity for big-money innovation will give them immunity in the crisis. Widespread homeworking will have broad consequences, from commercial-property values to urban demographics. And a seemingly innocuous Hong Kong history exam is a window into the territory’s increasingly fraught politics. 

For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/radiooffer


 

See acast.com/privacy for privacy and opt-out information.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Shot chasers: big pharma’s covid-19 boost

Shot chasers: big pharma’s covid-19 boost